Alessia Floerchinger, MSc

PhD Student
German Cancer Research Center (DKFZ) Heidelberg
Heidelberg, Baden-Wurttemberg, Germany

N/A

Presentation(s):

• (1554112) Combining CD19 CAR T cells with T cell-engaging bispecific antibody treatment enhances efficacy in murine models of CLL and ex vivo patient cultures

  Friday, October 6, 2023
  9:35 AM – 9:45 AM EDT